Y.Zhanetal.Biomedicine&Pharmacotherapy133(2021)110996
[83]C.S.Lewis,C.Voelkel-Johnson,C.D.Smith,Suppressionofc-MycandRRM2[90]M.Kim,J.G.Mun,H.J.Lee,S.R.Son,M.J.Lee,J.Y.Kee,Inhibitoryeffectofoat
expressioninpancreaticcancercellsbythesphingosinekinase-2inhibitorbranethanolextractonsurvivalandgemcitabineresistanceofpancreaticCancer
ABC294640,Oncotarget7(37)(2016)60181–60192.cells,Molecules24(21)(2019).
[84]M.Liang,T.Zhao,L.Ma,Y.Guo,CHK1inhibitionsensitizespancreaticcancercells[91]A.W.Nana,S.Y.Wu,Y.S.Yang,Y.T.Chin,T.M.Cheng,Y.Ho,W.S.Li,Y.M.Liao,Y.
togemcitabineviapromotingCDK-dependentDNAdamageandribonucleotideR.Chen,Y.J.Shih,Y.R.Liu,J.Pedersen,S.Incerpi,A.Hercbergs,L.F.Liu,
reductasedownregulation,Oncol.Rep.39(3)(2018)1322–1330.J.Whang-Peng,P.J.Davis,H.Y.Lin,Nano-diamino-Tetrac(NDAT)enhances
[85]G.Lopez,D.Braggio,A.Zewdu,L.Casadei,K.Batte,H.K.Bid,D.Koller,P.Yu,O.resveratrol-inducedantiproliferationbyactionontheRRM2pathwayincolorectal
H.Iwenofu,A.Strohecker,E.Choy,D.Lev,R.Pollock,Mocetinostatcombinedwithcancers,Horm.Cancer9(5)(2018)349–360.
gemcitabineforthetreatmentofleiomyosarcoma:preclinicalcorrelates,PLoSOne[92]R.Daylami,D.J.Muilenburg,S.Virudachalam,R.J.Bold,Pegylatedarginine
12(11)(2017),e0188859.deiminasesynergisticallyincreasesthecytotoxicityofgemcitabineinhuman
[86]R.J.Jones,V.Baladandayuthapani,S.Neelapu,L.E.Fayad,J.E.Romaguera,pancreaticcancer,J.Exp.Clin.CancerRes.33(1)(2014)102.
M.Wang,R.Sharma,D.Yang,R.Z.Orlowski,HDM-2inhibitionsuppresses[93]J.H.Cho,S.A.Kim,S.B.Park,H.M.Kim,S.Y.Song,Suppressionofpancreatic
expressionofribonucleotidereductasesubunitM2,andsynergisticallyenhancesadenocarcinomaupregulatedfactor(PAUF)increasesthesensitivityofpancreatic
gemcitabine-inducedcytotoxicityinmantlecelllymphoma,Blood118(15)(2011)cancertogemcitabineand5FU,andinhibitstheformationofpancreaticcancer
4140–4149.stemlikecells,Oncotarget8(44)(2017)76398–76407.
[87]W.Qi,X.Xu,M.Wang,X.Li,C.Wang,L.Sun,D.Zhao,L.Sun,InhibitionofWee1[94]N.Fatkhutdinov,K.Sproesser,C.Krepler,Q.Liu,P.A.Brafford,M.Herlyn,K.
sensitizesAMLcellstoATRinhibitorVE-822-inducedDNAdamageandapoptosis,M.Aird,R.Zhang,TargetingRRM2andmutantBRAFisanovelcombinatorial
Biochem.Pharmacol.164(2019)273–282.strategyformelanoma,Mol.cancerres.:MCR14(9)(2016)767–775.
[88]G.Jin,K.Wang,Y.Liu,X.Liu,X.Zhang,H.Zhang,Proteomiclevelchangeson[95]C.A.Kunos,S.M.Chiu,J.Pink,T.J.Kinsella,Modulatingradiationresistanceby
treatmentinMCF-7/DDPbreastCancerDrug-Resistantcells,AnticancerAgentsinhibitingribonucleotidereductaseincancerswithvirallyormutationallysilenced
Med.Chem.(2020).p53protein,Radiat.Res.172(6)(2009)666–676.
[89]Z.Wang,X.Liu,R.L.Ho,C.W.Lam,M.S.Chow,Precisionorpersonalizedmedicine[96]C.A.Kunos,T.Radivoyevitch,J.Pink,S.M.Chiu,T.Stefan,J.Jacobberger,T.
forCancerchemotherapy:istherearoleforherbalmedicine,Molecules21(7)J.Kinsella,Ribonucleotidereductaseinhibitionenhanceschemoradiosensitivityof
(2016).humancervicalcancers,Radiat.Res.174(5)(2010)574–581.
[97]R.L.Setten,J.J.Rossi,S.P.Han,ThecurrentstateandfuturedirectionsofRNAi-
basedtherapeutics,Naturereviews,Drugdiscovery18(6)(2019)421–446.
8 |
|
